Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience-Reference-Cited by-同舟云学术

Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience

Published:2023-04 Issue: Volume:183 Page:79-89
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Repetto Matteo^ORCID,Crimini Edoardo^ORCID,Boscolo Bielo Luca^ORCID,Guerini-Rocco Elena,Ascione Liliana^ORCID,Bonfanti Andrea,Zanzottera Cristina,Mazzarella Luca,Ranghiero Alberto,Belli Carmen^ORCID,Criscitiello Carmen^ORCID,Esposito Angela,Barberis Massimo C.P.,Curigliano Giuseppe^ORCID

Funder

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Precision oncology: origins, optimism, and potential;Prasad;Lancet Oncol,2016

2. Challenges and obstacles in applying therapeutical indications formulated in molecular tumor boards;Crimini;Cancers,2022

3. SnapShot: TCGA-analyzed tumors;Blum;Cell,2018

4. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair–deficient cancer: results from the phase II KEYNOTE-158 study;Marabelle;J Clin Oncol,2020

5. Larotrectinib: first global approval;Scott;Drugs,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular tumor board as a step in cancer patient management: a southern Italian experience;Frontiers in Medicine;2024-09-11

2. Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers;ESMO Open;2024-08

3. Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis;The Oncologist;2024-05-08

4. Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology;The Oncologist;2024-03-23

5. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing;Cancer Treatment Reviews;2024-01